
GC35505
BET-BAY 002
Also known as 2-[[(4R)-6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]methyl]-5-methyl-1,3,4-oxadiazole
BET-BAY 002 is a potent BET inhibitor; shows efficacy in a multiple myeloma model
ChemicalCAS1588521-78-1MW403.86FormulaC22H18ClN5O
- CAS number
- 1588521-78-1
- Molecular weight
- 403.86
- Formula
- C22H18ClN5O
- Solubility
- DMSO: ≥ 50 mg/mL (123·81 mM)
- InChIKey
- AGYIAWHWIUZNSD-INIZCTEOSA-N
- Catalogue number
- GC35505
- Brand
- GLPBIO
Computed properties PubChem CID 73425805 · XLogP 4.1 · TPSA 69.6 Ų · H-bond donors 0
- XLogP
- 4.1
- TPSA
- 69.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 3
- Heavy atoms
- 29
SMILES CC1=NN=C2N1C3=CC=CC=C3C(=C[C@H]2CC4=NN=C(O4)C)C5=CC=C(C=C5)Cl
Computed descriptors from PubChem (CID 73425805), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il